The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancerJ.E. Berchuck, Love Goyal, Francesco Facchinetti et al.|Annals of Oncology|2022Cited by 138
Silent mutations reveal therapeutic vulnerability in RAS Q61 cancersYoshihisa Kobayashi, Pasi A. Jänne, Fangxin Hong et al.|Nature|2022Cited by 62
TRK inhibitor in a patient with metastatic triple-negative breast cancer and <i>NTRK</i> fusions identified <i>via</i> cell-free DNA analysisArielle J. Medford, Aditya Bardia, Lauren Oshry et al.|Therapeutic Advances in Medical Oncology|2023Cited by 11
Development and validation of a computational histology artificial intelligence (CHAI) prognostic biomarker in renal cell carcinoma.Alex Zihao Zhu, Sumanta Kumar Pal, Viswesh Krishna et al.|Journal of Clinical Oncology|2026Cited by 0